Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole for prevention of gastrointestinal events during corticosteroid pulse therapy in multiple sclerosis
IRCT20201210049674N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of omeprazole in multiple sclerosis (MS) and gastrointestinal conditions, sponsored by Tehran University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
omeprazole
03
Conditions
multiple sclerosis (MS)gastrointestinal conditions
Beyond the preview
Go deeper on IRCT20201210049674N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201210049674N1.